@entity565 in @entity1 has characteristic features related to hormone secretion. Classically, the prevalence of @entity565 is higher in @entity1 than in @entity1 . Data in the literature are not all in agreement with this hypothesis and it would appear that for cultural and social reasons, @entity565 is under-diagnosed in young @entity1 . In the premenstrual context, sex hormones have a clear effect as reported in the literature in 30 to 40% of @entity748 @entity1 . Aggravation occurs readily in @entity1 with severe disease. During pregnancy, @entity565 can influence outcome unfavorably. It is advisable to follow these pregnancies closely and encourage good self-monitoring to minimize risks for the mother and fetus. In the peri- and post-menopausal period, @entity565 may worsen in @entity1 with @entity66 . The rate of disease onset during this period is also higher than in other age groups. @entity9646 replacement therapy can have an unfavorable effect on the incidence of @entity565 during this period.

[Influence of female sex on XXXX ].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'girls', 'boys'] @entity748 :: ('MESH:D013224', 'Disease') :: ['asthmatic'] @entity9646 :: ('MESH:D006728', 'Chemical') :: ['Hormone'] @entity66 :: ('MESH:D004194', 'Disease') :: ['prior disease'] @entity565 :: ('MESH:D001249', 'Disease') :: ['asthma', 'Asthma']
@entity565 :: (MESH:D001249,Disease) :: ['asthma']
